2-chloroadenosine has been researched along with Leukemia, Myeloid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, GS; Feng, LY; Jia, HT; Jia, XZ; Li, SY; Ni, JH; Yang, SY | 1 |
| Beutler, E; Carson, DA | 1 |
| Dumontet, C; Galmarini, CM; Mackey, JR | 1 |
| Blakley, RL; Crom, W; Kearns, C; Mirro, J; Santana, VM; Schell, MJ | 1 |
| Blakley, RL; Cherrie, J; Harwood, FC; Kalwinsky, D; Mirro, J; Santana, VM; Schell, M | 1 |
2 review(s) available for 2-chloroadenosine and Leukemia, Myeloid
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Topics: 2-Chloroadenosine; Apoptosis; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphocytes; Lymphoma | 1993 |
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Topics: 2-Chloroadenosine; 5'-Nucleotidase; Acute Disease; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Gemcitabine; Hematopoietic Cell Growth Factors; Humans; Leukemia, Myeloid; Lymphoproliferative Disorders; Neoplastic Stem Cells; Nucleosides; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Remission Induction; Ribonucleotide Reductases; Vidarabine | 2001 |
2 trial(s) available for 2-chloroadenosine and Leukemia, Myeloid
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Deoxyadenosines; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1992 |
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Topics: 2-Chloroadenosine; Adolescent; Adult; Child; Child, Preschool; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
1 other study(ies) available for 2-chloroadenosine and Leukemia, Myeloid
| Article | Year |
|---|---|
Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells.
Topics: 2-Chloroadenosine; Adenosine Triphosphate; Biocatalysis; DNA Damage; Humans; Hydrolysis; K562 Cells; Leukemia, Myeloid; Topoisomerase II Inhibitors | 2009 |